Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 173

Similar articles for PubMed (Select 17713470)

1.

The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB).

Owen RP, Klein TE, Altman RB.

Clin Pharmacol Ther. 2007 Oct;82(4):472-5. Epub 2007 Aug 22.

PMID:
17713470
2.

PharmGKB summary: peginterferon-╬▒ pathway.

Shuldiner SR, Gong L, Muir AJ, Altman RB, Klein TE.

Pharmacogenet Genomics. 2015 Jun 23. [Epub ahead of print] No abstract available.

PMID:
26111151
3.

Clinical pharmacogenetics implementation consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update.

Saito Y, Stamp LK, Caudle KE, Hershfield M, McDonagh EM, Callaghan JT, Tassaneeyakul W, Mushiroda T, Kamatani N, Goldspiel BR, Phillips EJ, Klein TE, Lee MT.

Clin Pharmacol Ther. 2015 Jun 10. doi: 10.1002/cpt.161. [Epub ahead of print]

PMID:
26094938
4.

PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses.

Mazaleuskaya LL, Sangkuhl K, Thorn CF, FitzGerald GA, Altman RB, Klein TE.

Pharmacogenet Genomics. 2015 Jun 5. [Epub ahead of print] No abstract available.

PMID:
26049587
5.

Enabling the curation of your pharmacogenetic study.

McDonagh Em, Whirl-Carrillo M, Altman RB, Klein TE.

Clin Pharmacol Ther. 2015 Feb;97(2):116-9. doi: 10.1002/cpt.15. Epub 2014 Dec 20.

6.

PharmGKB summary: very important pharmacogene information for human leukocyte antigen B.

Barbarino JM, Kroetz DL, Klein TE, Altman RB.

Pharmacogenet Genomics. 2015 Apr;25(4):205-21. doi: 10.1097/FPC.0000000000000118. No abstract available.

PMID:
25647431
7.

PharmGKB summary: very important pharmacogene information for CFTR.

McDonagh EM, Clancy JP, Altman RB, Klein TE.

Pharmacogenet Genomics. 2015 Mar;25(3):149-56. doi: 10.1097/FPC.0000000000000112. No abstract available.

8.

PharmGKB summary: ibuprofen pathways.

Mazaleuskaya LL, Theken KN, Gong L, Thorn CF, FitzGerald GA, Altman RB, Klein TE.

Pharmacogenet Genomics. 2015 Feb;25(2):96-106. doi: 10.1097/FPC.0000000000000113. No abstract available.

9.

PharmGKB summary: very important pharmacogene information for CYP4F2.

Alvarellos ML, Sangkuhl K, Daneshjou R, Whirl-Carrillo M, Altman RB, Klein TE.

Pharmacogenet Genomics. 2015 Jan;25(1):41-7. doi: 10.1097/FPC.0000000000000100. No abstract available.

PMID:
25370453
10.

Pharmacogenetic information for patients on drug labels.

Haga SB, Mills R, Moaddeb J.

Pharmgenomics Pers Med. 2014 Oct 3;7:297-305. doi: 10.2147/PGPM.S67876. eCollection 2014.

11.

Assessment of the pharmacogenomics educational environment in Southeast Europe.

Pisanu C, Tsermpini EE, Mavroidi E, Katsila T, Patrinos GP, Squassina A.

Public Health Genomics. 2014;17(5-6):272-9. doi: 10.1159/000366461. Epub 2014 Oct 17.

PMID:
25341999
12.

Public health pharmacogenomics.

Patrinos GP.

Public Health Genomics. 2014;17(5-6):245-7. doi: 10.1159/000366459. Epub 2014 Oct 17. No abstract available.

PMID:
25341918
13.

DruGeVar: an online resource triangulating drugs with genes and genomic biomarkers for clinical pharmacogenomics.

Dalabira E, Viennas E, Daki E, Komianou A, Bartsakoulia M, Poulas K, Katsila T, Tzimas G, Patrinos GP.

Public Health Genomics. 2014;17(5-6):265-71. doi: 10.1159/000365895. Epub 2014 Sep 9.

PMID:
25228099
14.

Potential applications of pharmacogenomics to heart failure therapies.

Parikh KS, Ahmad T, Fiuzat M.

Heart Fail Clin. 2014 Oct;10(4):599-606. doi: 10.1016/j.hfc.2014.07.007. Epub 2014 Aug 15. Review.

PMID:
25217435
15.

PharmGKB Drug Data Normalization with NDF-RT.

Zhu Q, Freimuth RR, Pathak J, Chute CG.

AMIA Jt Summits Transl Sci Proc. 2013 Mar 18;2013:180. eCollection 2013.

PMID:
24303334
17.

[Personalised pharmacogenetics. Evidence-based guidelines and clinical application of pharmacogenetic diagnostics].

Stingl JC, Brockm├Âller J.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Nov;56(11):1509-21. doi: 10.1007/s00103-013-1822-2. Review. German.

PMID:
24170080
18.

To replicate or not to replicate: the case of pharmacogenetic studies: Have pharmacogenomics failed, or do they just need larger-scale evidence and more replication?

Ioannidis JP.

Circ Cardiovasc Genet. 2013 Aug;6(4):413-8; discussion 418. doi: 10.1161/CIRCGENETICS.113.000106. No abstract available.

19.

A massive open online course on pharmacogenomics: not just disruptive innovation but a possible solution.

Ma JD, Lee KC, Kuo GM.

Pharmacogenomics. 2013 Jul;14(10):1125-7. doi: 10.2217/pgs.13.97. No abstract available.

PMID:
23859565
20.

PharmGKB: the Pharmacogenomics Knowledge Base.

Thorn CF, Klein TE, Altman RB.

Methods Mol Biol. 2013;1015:311-20. doi: 10.1007/978-1-62703-435-7_20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk